Becton Dickinson Profit Margin 2006-2018 | BDX

Current and historical gross margin, operating margin and net profit margin for Becton Dickinson (BDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Becton Dickinson net profit margin as of September 30, 2018 is 1.47%.
Becton Dickinson Annual Profit Margins
Becton Dickinson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $65.088B $15.983B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $25.557B 9.76
AmerisourceBergen (ABC) United States $19.225B 13.71
Align Technology (ALGN) United States $18.873B 48.15
Laboratory Of America Holdings (LH) United States $17.168B 15.54
Cardinal Health (CAH) United States $16.479B 11.06
Cooper (COO) United States $13.160B 23.70
Henry Schein (HSIC) United States $13.023B 21.41
West Pharmaceutical Services (WST) United States $8.221B 40.80
DENTSPLY SIRONA (XRAY) United States $8.025B 16.03
Merit Medical Systems (MMSI) United States $3.238B 38.42
Patterson (PDCO) United States $2.259B 15.88
STAAR Surgical (STAA) United States $2.074B 213.64
CONMED (CNMD) United States $1.944B 32.29
Atrion (ATRI) United States $1.321B 37.76
Antares Pharma (ATRS) United States $0.573B 0.00
Invacare (IVC) United States $0.230B 0.00
Lifevantage (LFVN) United States $0.167B 23.70
Endologix (ELGX) United States $0.115B 0.00
Aceto (ACET) United States $0.055B 0.00
Pro-Dex (PDEX) United States $0.051B 32.63
Biolase (BIOL) United States $0.030B 0.00